Evidence map›Paper›PMID 30208586›Full record

ArticleInternational journal of molecular sciences2018

Can Plasma Rich in Growth Factors Be Safe for Parental Use? A Safety Study in the Canine Model.

Elena Damiá, Deborah Chicharro, Mónica Rubio, José María Carrillo, Joaquín Sopena, Belén Cuervo, Sergio López, José Manuel Vilar

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elena DamiáBioregenerative Medicine and Applied Surgery Research Group, Department of Animal Medicine and Surgery, Faculty of Veterinary, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain. elena.damia@uchceu.es.
Deborah ChicharroBioregenerative Medicine and Applied Surgery Research Group, Department of Animal Medicine and Surgery, Faculty of Veterinary, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain. debora.chicharro@uchceu.es.ORCID 0000-0002-1121-1327
Mónica RubioBioregenerative Medicine and Applied Surgery Research Group, Department of Animal Medicine and Surgery, Faculty of Veterinary, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain. mrubio@uchceu.es.ORCID 0000-0002-2689-8862
José María CarrilloBioregenerative Medicine and Applied Surgery Research Group, Department of Animal Medicine and Surgery, Faculty of Veterinary, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain. jcarrill@uchceu.es.
Joaquín SopenaBioregenerative Medicine and Applied Surgery Research Group, Department of Animal Medicine and Surgery, Faculty of Veterinary, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain. jsopena@uchceu.es.ORCID 0000-0002-3601-9745
Belén CuervoBioregenerative Medicine and Applied Surgery Research Group, Department of Animal Medicine and Surgery, Faculty of Veterinary, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain. belen.cuervo@uchceu.es.ORCID 0000-0002-8104-4560
Sergio LópezDepartment of Animal Pathology, Instituto Universitario de Investigaciones Biomédicas y Universitarias, Universidad de Las Palmas de Gran Canaria, 35416 Trasmontaña S/N. Arucas, Spain. sergiolopezbarbeta@gmail.com.
José Manuel VilarDepartment of Animal Pathology, Instituto Universitario de Investigaciones Biomédicas y Universitarias, Universidad de Las Palmas de Gran Canaria, 35416 Trasmontaña S/N. Arucas, Spain. jose.vilar@ulpgc.es.ORCID 0000-0002-2060-2274
Universidad Cardenal Herrera CEU · ESUniversidad de Las Palmas de Gran Canaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low invasiveness is the main goal of modern surgery. The use of platelet-rich plasma (PRP) is known to be effective in a variety of applications, such as oral, maxillofacial, orthopedic, dermatologic and cosmetic surgeries. However, a potential ergogenic and carcinogenic effect of PRP derivatives by means of the insulin-like growth factor-1 (IGF-1) pathway has been suggested. Because of this notion, the purpose of this study is to assess the effect of a commercially available PRP-derivative intramuscular injection in the lumbar muscular tissue (local effect) and to determine the IGF-1 blood concentration (systemic effect) on healthy beagle dogs. Local effect was evaluated by computed tomography (CT) scan and echography, and systemic effect was calculated by blood testing on days 0, 14, 28, 42 and 56. No statistically significant changes were observed; thus, PRGF could be considered safe when using therapeutic doses.

Indexed as

Platelet-Rich PlasmaAnimalsDogsFemaleHumansInjections, IntramuscularInsulin-Like Growth Factor ILumbosacral RegionMaleInsulin-Like Growth Factor Icanineinsulin-like growth factor-1 (IGF-1)plasma rich in growth factors (PRGF)platelet-rich plasma (PRP)

Identifiers

PMID30208586
PMCPMC6164142
OpenAlexW2891930494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.